Assembly Biosciences ASMB
NASDAQ ASMB
$21.60 +0.41 (+1.93%)
As of: Oct 21, 2026 · 10:23 AM EDT

Assembly Biosciences (ASMB) Non-Current Debt (2010 - 2011)

Updated

Assembly Biosciences (ASMB) posted Non-Current Debt of $1.32 million for Q2 2011.

Analysis

Assembly Biosciences (ASMB) Non-Current Debt (2010 - 2011) Analysis & Trends

At the end of FY2010, Assembly Biosciences' Non-Current Debt came in at $1.27 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,132.34 Bn 1,100.93 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 615.91 Bn 534.44 Bn 17.26 Bn 37.34 Bn
3 AbbVie 505.47 Bn 478.59 Bn 12.70 Bn 62.48 Bn
4 Merck 368.25 Bn 322.63 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.18 Bn 262.17 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 23.68 Bn
7 Amgen 236.22 Bn 191.62 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 190.68 Bn 164.87 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.14 Bn 116.79 Bn 10.94 Bn 60.50 Bn
10 Assembly Biosciences 407.24 Mn -620.39 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2011 1.32 Mn
Dec 31, 2010 1.27 Mn
API Access

Assembly Biosciences Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ASMB&period=max&api_key=YOUR_API_KEY